| Literature DB >> 25495422 |
Kyuho Moon1, Beomkoo Chung2, Yoonho Shin1, Arnold L Rheingold3, Curtis E Moore3, Sung Jean Park4, Sunghyouk Park1, Sang Kook Lee1, Ki-Bong Oh2, Jongheon Shin1, Dong-Chan Oh1.
Abstract
The combination of investigating a unique source of chemically prolific bacterium with an LC/MS-based bacterial strain selection approach resulted in the discovery of two new secondary metabolites, buanmycin (1) and buanquinone (2), from the culture of a marine Streptomyces strain, which was isolated from a tidal mudflat in Buan, Republic of Korea. The carbon backbone of buanmycin (1), comprising 20 quaternary carbons out of 30 total carbons, was determined via (13)C-(13)C COSY NMR analysis after labeling 1 with (13)C by culturing the bacterium with (13)C-glucose. The complete structure of 1 was confidently elucidated, primarily based on 1D and 2D NMR spectroscopic and X-ray crystallographic analysis, as that of a new pentacyclic xanthone. The absolute configuration of the α-methyl serine unit in 1 was established by applying the advanced Marfey's method. The structure of buanquinone (2) was determined to be a new pentacyclic quinone based on NMR and MS spectroscopic data. Buanmycin exhibited potent cytotoxicity against colorectal carcinoma cells (HCT-116) and gastric carcinoma cells (SNU-638) with submicromolar IC50 values and strongly inhibited the pathogenic Gram-negative bacterium Salmonella enterica (MIC = 0.7 μM). In particular, buanmycin demonstrated inhibition of sortase A, which is a promising target for antibiotic discovery.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25495422 DOI: 10.1021/np500736b
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050